The Journal of the National Cancer Institute Monographs, No. 31, "Future Directions in Epidemiologic and Preventive Research on Human Papillomaviruses and Cancer," provides up-to-date coverage on various areas of HPV research. The monograph includes information about the natural history of HPV, immunosuppression, vaccines, cofactors that promote cancer, and descriptive epidemiology. The monograph, edited by Dr. F. Xavier Bosch of the Catalan Institute of Oncology in Barcelona, Spain, and Drs. Mark Schiffman and Diane Solomon of NCI, is the result of a June 2002 workshop at NCI. The full text of this JNCI monograph can be found at: http://jncicancerspectrum.oupjournals.org/jncimono/
content/vol2003/issue31/.

People
Dr. Richard Kaplan, chief of the Clinical Investigations Branch (CIB) of NCI's Cancer Therapy Evaluation Program (CTEP), has accepted a position as associate director of the National Cancer Research Network (NCRN) in the United Kingdom, and as professor of clinical cancer studies at the University of Leeds. At NCRN, Dr. Kaplan will develop and manage its trials portfolio, coordinate priorities with major sources of funding, promote productive links with industry, and facilitate the integration of related objectives into more trials, among other responsibilities. He also will assist the chief executive of Cancer Research U.K. (CRUK) with the clinical research components of its funding portfolio.

Dr. Kaplan has had a distinguished career with NCI, beginning as a clinical associate in the intramural program in 1971. In 1992, he began his position with CIB/CTEP and was named branch chief in 2000. While at CTEP, Dr. Kaplan played crucial roles in restructuring clinical trials, as well as creating and expanding the Brain Tumor Consortia.

Dr. Beverly Mock has been appointed chief of the Laboratory of Genetics in NCI's Center for Cancer Research (CCR). Dr. Mock is an internationally recognized mouse geneticist whose research has concentrated on cancer as a complex genetic trait. Her work has focused on identifying genes involved in the predisposition of inbred strains of mice to develop plasma cell and skin tumors.

Dr. Mock has served as CCR's associate director of scientific planning since 1999. In addition to her administrative and scientific contributions to CCR, she has served as head of the NIH-wide Genetics Interest Group, and as committee chair for the International Mouse Genome Society for the compilation of linkage maps of mouse chromosomes 4 and 15.

Dr. Gilbert Wheeler Beebe, NCI epidemiologist renowned for his monumental studies of populations exposed to ionizing radiation, died at age 90 in March 2003. Following his death, NCI's Radiation Epidemiology Branch (REB) created a memorial fund in his name, which will award travel funds for young investigators attending the Radiation Research Society (RRS) Annual Meeting. The next RRS meeting will be held in April 2004 in St. Louis, Mo. The memorial is just one of several awards honoring Dr. Beebe for the enormous influence of a nearly 70-year career. He played key roles in major epidemiological studies, from the effects of the 1945 atomic bombings in Japan to the study of thyroid cancer and leukemia risk among populations after the Chernobyl accident.

Dr. Stuart Yuspa, chief, Laboratory of Cellular Carcinogenesis and Tumor Promotion, and deputy director, Center for Cancer Research, NCI, will be presented in April with the annual Stephen Rothman Memorial Award. This is the highest honor bestowed by the Society for Investigative Dermatology. Recipients of this tribute have made major scientific contributions to cutaneous biology and excelled as mentors and recruiters of outstanding young investigators in the field. Awardees have distinctly altered the course and image of cutaneous biology, clinical dermatology, and its allied fields.

Dr. Michael Bishop received the 2003 Distinguished Clinical Teacher's Award from the NIH Fellows Committee for his role in mentoring, teaching, patient care, and clinical research. Bishop serves as the clinical head of the Stem Cell Transplantation Program in the Experimental Transplantation and Immunology Branch, within the Center for Cancer Research, NCI.